Literature DB >> 16799642

Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.

A Oloumi1, S Syam, S Dedhar.   

Abstract

The Wnt gene family encodes secreted signaling molecules that play important roles in tumorgenesis and embryogenesis. The canonical Wnt signaling pathway regulates target gene expression via the stabilization and nuclear translocation of the cytoplasmic pool of beta-catenin. The activation of integrin-linked kinase (ILK) is also known to regulate the stabilization and subsequent nuclear translocation of beta-catenin in several epithelial cell models. We now report that molecular and pharmacological inhibition of ILK activity in mammalian cells directly modulates Wnt signaling by suppressing the stabilization and nuclear translocation of beta-catenin, as well as beta-catenin/Lef-mediated transcription. Inhibition of ILK activity, but not phosphatidylinositol-3 kinase (PI3K) or MEK activities suppresses nuclear beta-catenin stabilization in cells stably expressing Wnt3a as well as in cells exposed to either Wnt3a conditioned media or purified Wnt3a. Furthermore, ILK inhibition reverses the Wnt3a-induced suppression of beta-catenin phosphorylation that accompanies beta-catenin stabilization. In addition, we show that ILK can be identified in a complex with Wnt pathway components such as adenomatous polyposis coli and GSK-3. Upon treatment of L cells with Wnt3a-CM, glycogen synthase kinase-3 (GSK-3beta) becomes highly phosphorylated on Ser 9, which is completely abolished upon inhibition of ILK activity. However, acute exposure of L cells to purified Wnt3a does not result in the stimulation of GSK-3beta Ser 9 phosphorylation, despite beta-catenin stabilization. Together our data demonstrate that ILK activity can modulate acute Wnt3a mediated beta-catenin phosphorylation, stabilization and nuclear activation in a PI3K-independent manner, as well as the more prolonged PI3K-dependent secondary effects of Wnt signaling on GSK-3 phosphorylation. Finally, we suggest that a novel small molecule inhibitor of ILK, QLT-0267, may be a useful tool in the regulation of pathological Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799642     DOI: 10.1038/sj.onc.1209752

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment.

Authors:  Yubing Sun; Christopher S Chen; Jianping Fu
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

2.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

Authors:  Young Sun Kang; Yingjian Li; Chunsun Dai; Lawrence P Kiss; Chuanyue Wu; Youhua Liu
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

3.  Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.

Authors:  Keane K Y Lai; Soo-Mi Kweon; Feng Chi; Edward Hwang; Yasuaki Kabe; Reiichi Higashiyama; Lan Qin; Rui Yan; Raymond P Wu; Keith Lai; Naoaki Fujii; Samuel French; Jun Xu; Jian-Ying Wang; Ramachandran Murali; Lopa Mishra; Ju-Seog Lee; James M Ntambi; Hidekazu Tsukamoto
Journal:  Gastroenterology       Date:  2017-01-29       Impact factor: 22.682

Review 4.  Crossroads of integrins and cadherins in epithelia and stroma remodeling.

Authors:  Carolina Epifano; Mirna Perez-Moreno
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

5.  Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer.

Authors:  En-Chi Hsu; Samuel K Kulp; Han-Li Huang; Huang-Ju Tu; Min-Wu Chao; Yu-Chou Tseng; Ming-Chen Yang; Santosh B Salunke; Nicholas J Sullivan; Wen-Chung Chen; Jianying Zhang; Che-Ming Teng; Wen-Mei Fu; Duxin Sun; Max S Wicha; Charles L Shapiro; Ching-Shih Chen
Journal:  Carcinogenesis       Date:  2016-02-19       Impact factor: 4.944

6.  Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.

Authors:  Zuzana Saidak; Carole Le Henaff; Sofia Azzi; Caroline Marty; Sophie Da Nascimento; Pascal Sonnet; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

7.  Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.

Authors:  Alessandra De Robertis; Silvia Valensin; Marco Rossi; Patrizia Tunici; Margherita Verani; Antonella De Rosa; Cinzia Giordano; Maurizio Varrone; Arianna Nencini; Carmela Pratelli; Tiziana Benicchi; Annette Bakker; Jeffrey Hill; Kanda Sangthongpitag; Vishal Pendharkar; Boping Liu; Fui Mee Ng; Siew Wen Then; Shi Jing Tai; Seong-Moon Cheong; Xi He; Andrea Caricasole; Massimiliano Salerno
Journal:  Mol Cancer Ther       Date:  2013-04-25       Impact factor: 6.261

8.  Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation.

Authors:  Mykola Maydan; Paul C McDonald; Jasbinder Sanghera; Jun Yan; Charalampos Rallis; Sheena Pinchin; Gregory E Hannigan; Leonard J Foster; David Ish-Horowicz; Michael P Walsh; Shoukat Dedhar
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

9.  Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.

Authors:  Arusha Oloumi; Mykola Maidan; Frances E Lock; Howard Tearle; Steven McKinney; William J Muller; Samuel A J R Aparicio; Shoukat Dedhar
Journal:  Breast Cancer Res       Date:  2010-06-21       Impact factor: 6.466

10.  Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2.

Authors:  Steve P Crampton; Beibei Wu; Edward J Park; Jai-Hyun Kim; Candice Solomon; Marian L Waterman; Christopher C W Hughes
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.